HCAT today
$1.44+$0.01 (+0.70%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourStrong Bearish
15 minStrong Bearish
5 minStrong Bearish
Daily trend turns up above $1.84
Key levels
Resistance$1.70
Resistance$1.56
Support$1.28
Support$1.11
Latest news & SEC filings
GuidanceHealth Catalyst Cuts Outlook Alongside Quarterly Results
EarningsHealth Catalyst Posts Q3 2026 Results
EarningsHealth Catalyst holds Q3 2026 earnings call
EarningsHealth Catalyst posts smaller Q3 adjusted loss than expected, revenue tops forecast
All HCAT news →About Health Catalyst
Health Catalyst supplies data and analytics technology and services to healthcare organizations. Its offering combines a cloud-based data platform called Ignite, software analytics applications, and expert services. Clients are mainly healthcare providers, including large hospital systems, community hospitals, physician groups, and insurers. The company operates mainly in the United States and also does business in parts of Asia and Europe.
Based on the company's 10-K filed Mar 12, 2026.
Nasdaq · Technology
Health Catalyst, Inc. (HCAT)
What Is the Price Target for HCAT?
SEPT Low Target
$1.50
SEPT Mid Target
$1.77
SEPT High Target
$2.00
Analyst Consensus
$1.77
Is HCAT a Buy or Sell Right Now?
Thesis
- •Revenue growing 1.5% YoY with SLOWING trend — consistent growth.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for HCAT.
Start Free Trial →Is HCAT Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
P/B, Analyst Consensus
Fair Value
$2.31
10
Moat Score
NONE
5/9
Piotroski Score
-3.8
Altman Z-Score
What Is Smart Money Doing with HCAT?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
MEDIUM
Signal: NEUTRAL
Recent Insider Activity
| Name | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Reller Tami | director | Buy | 128,851 | - | Oct 1, 2026 |
| Albert Benjamin | director officer | Sale | 35,244 | $59K | Sep 10, 2026 |
| Albert Benjamin | director officer | Sale | 34,485 | $58K | Jun 10, 2026 |
| Albert Benjamin | director officer | Sale | 336 | $460.39 | Jun 1, 2026 |
| Landry Benjamin | officer | Sale | 13,779 | $19K | Jun 1, 2026 |
| Alger Jason | officer | Sale | 18,804 | $26K | Jun 1, 2026 |
| Larson-Green Julie | director | Buy | 12,710 | - | Jun 1, 2026 |
| Llewelyn Linda | officer | Sale | 8,519 | $12K | Jun 1, 2026 |
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →HCAT Growth Story
Revenue YoY
1.5%
3yr Revenue CAGR
4.0%
EPS Growth YoY
-121.74%
FCF Growth YoY
-101.8%
Revenue Trend
SLOWING
Dark Pool Trades for HCAT
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for HCAT, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 14:36:47 | $1.48 | 3,000 | $$4K | BUY |
| 14:36:45 | $1.47 | 5,000 | $$7K | BUY |
| 14:36:44 | $1.47 | 5,000 | $$7K | BUY |
| 20:59:45 | $1.44 | 2,500 | $$4K | SELL |
| 20:58:19 | $1.44 | 1,700 | $$2K | BUY |
5 dark pool trades shown · $$25K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for Health Catalyst, Inc. (HCAT) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (2 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →HCAT — frequently asked questions
What is HCAT stock price today?
Health Catalyst, Inc. (HCAT) is at $1.44, up 0.70% (+$0.01) at the Nov 12, 2026 close.
Why is HCAT stock moving today?
Latest HCAT news — Nov 11, 2026: Health Catalyst Cuts Outlook Alongside Quarterly Results · Nov 6, 2026: Health Catalyst Posts Q3 2026 Results
What is the HCAT price target?
The average analyst price target for HCAT is $1.77, ranging from $2 to $2, based on 4 analysts. Latest: Canaccord Genuity downgrade on Aug 21, 2026.
What do analysts rate HCAT?
Analyst ratings for HCAT: 0 Buy, 5 Hold, 1 Sell — consensus Hold.
Did HCAT beat earnings?
HCAT last reported on Nov 5, 2026: EPS $0.53 vs -$0.05 expected — a beat of 1239.8%.
Does HCAT pay a dividend?
HCAT does not currently pay a dividend.
How much debt does HCAT have?
Health Catalyst, Inc. reported $153M of debt and $61M of cash (Jun 30, 2026).
What are HCAT support and resistance levels?
Support: $1.28, $1.11, $0.95. Resistance: $1.56, $1.70, $1.84.
What are insiders doing with HCAT?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on HCAT?
Nov 11, 2026: Health Catalyst Cuts Outlook Alongside Quarterly Results · Nov 6, 2026: Health Catalyst Posts Q3 2026 Results · Nov 5, 2026: Health Catalyst holds Q3 2026 earnings call